Our products come from years of research and development performed by world-renowned immunologists—our founders, Yang Liu, PhD, and Pan Zheng, MD, PhD.
Anchored by a team of business strategists and operations leaders with a proven history of getting products through clinical development, we are poised to offer patients battling evasive cancers a more promising path forward.
Collaboration
We maintain a dedicated and highly experienced business development team with strong expertise. Our business development strategy focuses on expanding and advancing our pipeline through both internal R&D and strategic external collaborations. A key example is our collaboration with BioNTech to develop and commercialize gotistobart. We intend to continue implementing this hybrid model of internal development and external partnerships to maximize the scientific, clinical, and commercial value of our programs.
Interested in joining our team of world-renowned scientists and leaders?
